Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Predicting Risk of Diabetic Retinopathy From Retinal Vessel Analysis

Predicting Risk of Diabetic Retinopathy From Retinal Vessel Analysis EDITORIAL Predicting Risk of Diabetic Retinopathy From Retinal Vessel Analysis Personalized Medicine in Transition ESPITE SIGNIFICANT ADVANCES IN THERA- deserves discussion. Although increasing caliber of ar- peutic strategies, diabetic retinopathy re- terioles appeared to be modestly associated with reti- mains a leading cause of preventable vi- nopathy incidence and progression, these associations did sion loss among working-aged people in not reach statistical significance. This is a somewhat un- D many developed countries. In the United expected finding as several prospective studies, includ- States, about 1 in 4 diabetic patients has signs of retinopa- ing an earlier report from the WESDR, have previously thy and 1 in 20 has vision-threatening retinopathy. Be- demonstrated a positive association between larger reti- cause early treatment is associated with better outcomes, nal arteriolar caliber at baseline and incident retinopa- 8,9 clinicians routinely try to estimate a patient’s risk of visual thy in patients with type 1 and type 2 diabetes. In ad- morbidity from diabetic retinopathy based on traditional dition, experimental studies offer good evidence that risk factors (eg, diabetes duration, glycemic control, and retinal arteriolar dilatation is an early physiological in- blood pressure control) and retinopathy severity. dicator of impaired arteriolar autoregulation related http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Ophthalmology American Medical Association

Predicting Risk of Diabetic Retinopathy From Retinal Vessel Analysis

JAMA Ophthalmology , Volume 130 (6) – Jun 1, 2012

Loading next page...
 
/lp/american-medical-association/predicting-risk-of-diabetic-retinopathy-from-retinal-vessel-analysis-3sCxKKF83E
Publisher
American Medical Association
Copyright
Copyright 2012 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6165
eISSN
2168-6173
DOI
10.1001/archophthalmol.2012.727
pmid
22801841
Publisher site
See Article on Publisher Site

Abstract

EDITORIAL Predicting Risk of Diabetic Retinopathy From Retinal Vessel Analysis Personalized Medicine in Transition ESPITE SIGNIFICANT ADVANCES IN THERA- deserves discussion. Although increasing caliber of ar- peutic strategies, diabetic retinopathy re- terioles appeared to be modestly associated with reti- mains a leading cause of preventable vi- nopathy incidence and progression, these associations did sion loss among working-aged people in not reach statistical significance. This is a somewhat un- D many developed countries. In the United expected finding as several prospective studies, includ- States, about 1 in 4 diabetic patients has signs of retinopa- ing an earlier report from the WESDR, have previously thy and 1 in 20 has vision-threatening retinopathy. Be- demonstrated a positive association between larger reti- cause early treatment is associated with better outcomes, nal arteriolar caliber at baseline and incident retinopa- 8,9 clinicians routinely try to estimate a patient’s risk of visual thy in patients with type 1 and type 2 diabetes. In ad- morbidity from diabetic retinopathy based on traditional dition, experimental studies offer good evidence that risk factors (eg, diabetes duration, glycemic control, and retinal arteriolar dilatation is an early physiological in- blood pressure control) and retinopathy severity. dicator of impaired arteriolar autoregulation related

Journal

JAMA OphthalmologyAmerican Medical Association

Published: Jun 1, 2012

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month